Disease-specific indications
New outcomes data and research has defined which patients can benefit from hematopoietic cell transplant (HCT) and when this therapy is best applied. HCT offers a potential cure for blood cancers, such as leukemia and lymphoma, and other life-threatening diseases.
Acute lymphoblastic leukemia (ALL)
Myelodysplastic syndromes (MDS)
Chronic myeloid leukemia (CML)
Myeloproliferative neoplasms (MPN)
Chronic lymphocytic leukemia (CLL)
Neuroblastoma
Ewing family of tumors
Medulloblastoma
Inherited metabolic disorders
Hemophagocytic lymphohistiocytosis (HLH)
Severe aplastic anemia
Other marrow failure diseases
Systemic sclerosis (SS)
Multiple Sclerosis (MS)
Sickle cell disease (SCD)
Transfusion-dependent thalassemias
HCT data trends
Overall volume trends and indications for transplantation show autologous and allogeneic HCT volume, age trends and disease indications for transplant.
This data was prepared by the CIBMTR® (Center for International Blood and Marrow Transplant Research®), a research collaboration between NMDPSM and the Medical College of Wisconsin.
Outcomes data
Consultation timing data
Post-transplant data
Outcomes and indications by disease
Access current research, outcomes and consultation guidelines & outcomes below to support your clinical decision-making.
Adult leukemia and myelodysplasia
Acute myeloid leukemia (AML)Acute lymphoblastic leukemia (ALL)
Myelodysplastic syndromes (MDS)
Chronic myeloid leukemia (CML)
Myeloproliferative neoplasms (MPN)
Chronic lymphocytic leukemia (CLL)
Pediatric leukemia and myelodysplasia
Acute myeloid leukemia (AML)
Acute lymphoblastic leukemia (ALL)
Myelodysplastic syndromes (MDS)
Lymphomas
Non-Hodgkin lymphoma (NHL)
Hodgkin lymphoma (HL)
Plasma cell disorders
Multiple myeloma
Light chain amyloidosis
POEMS syndrome (osteosclerotic myeloma)
Other malignant diseases
Germ cell tumorsNeuroblastoma
Ewing family of tumors
Medulloblastoma
Non-malignant disorders
Immune deficiency diseasesInherited metabolic disorders
Hemophagocytic lymphohistiocytosis (HLH)
Severe aplastic anemia
Other marrow failure diseases
Systemic sclerosis (SS)
Multiple Sclerosis (MS)
Sickle cell disease (SCD)
Transfusion-dependent thalassemias